Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' NEGRIN R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 29 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bensinger, WI; Martin, PJ; Storer, B; Clift, R; Forman, SJ; Negrin, R; Kashyap, A; Flowers, MED; Lilleby, K; Chauncey, TR; Storb, R; Rowley, S; Heimfeld, S; Blume, K
      Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

      NEW ENGLAND JOURNAL OF MEDICINE
    2. Negrin, R
      MAb therapy comes of age

      CYTOTHERAPY
    3. Nash, RA; Kurzrock, R; DiPersio, J; Vose, J; Linker, C; Maharaj, D; Nademanee, AP; Negrin, R; Nimer, S; Shulman, H; Ashby, M; Jones, D; Appelbaum, FR; Champlin, R
      A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    4. Yunes-Saab, P; Llerena-Rojas, L; Valdes-Rucabado, JA; de la Vega, AR; Aranguren-Ibanez, P; Perez-Fleitas, JL; Silva-Paradela, S; Gutierrez-Fernandez, F; Remon-Martin, J; Villar, R; Gonzalez, JL; Toruncha-Chukram, A; Mora-Guevara, E; Mendez-Peralta, T; Ramos-Emperador, C; Concepcion-Chacon, R; Castro-Arca, A; Claro-Valdes, R; Torres-Iribar, W; Pereda-Gonzalez, R; Martinez, L; Ceruto-Santander, LA; Obregon, G; Blas-Ledesma, S; Sordo-Diaz, R; Ibargoyin, R; Milan-Castillo, R; Perez-Galvez, I; Martinez-Espinosa, C; Padron-Pena, G; Urbay-Ruiz, A; Jacobo-Lavin, C; Lopez-Pedraza, G; Lorda, O; Adan-Sanchez, A; Rodriguez-Lopez, A; Gonzalez-Anca, M; Dominguez-Fernandez, J; Santos-Garcia, R; Flores-Gomez, R; Malleuve-Palancar, JR; del Rio-Caballero, G; Peru-Martinez, I; Pena-Roger, E; Lage-Meneses, M; Rodriguez-Rodriguez, E; Ferrin, JI; Hernandez-Garrido, L; Negrin-de la Rosa, R; Sanchez-Padron, A; Lopez-Rodriguez, R; Pastrana-Roman, I; Alvarez-Medina, AM; Garcia-Miranda, G; Martinez-Rojas, R; Gonzalez, E; Campos-Gutierrez, L; Ramirez-Navarro, C; Gonzalez, C; Ramirez-Dominguez, L; Dopico-Hernandez, A; Marquez-Romero, H; Melo, R; Cuza-Diaz, A; Mawad-Gonzalez, ME; Barciela, E; Hurtado-Baez, G; Moreira, R; Marrero-Miragaya, MA
      TERIMA-2: National extension of thrombolytic treatment with recombinant streptokinase in acute myocardial infarct in Cuba

      THROMBOSIS AND HAEMOSTASIS
    5. Mano-Negrin, R; Kirschenbaum, A
      Men and women's job histories and job changes - The case of Israel's medical-sector employees

      INTERNATIONAL JOURNAL OF MANPOWER
    6. Verfaillie, CM; Ploemacher, R; Di Persio, J; Sutherland, R; Serke, S; Johnsen, H; Noga, S; Negrin, R
      ISHAGE Scientific Committee Report - Assays to determine hematopoietic stem cell content in blood or marrow grafts

      CYTOTHERAPY
    7. Hensley, ML; Schuchter, LM; Lindley, C; Meropol, NJ; Cohen, GI; Broder, G; Gradishar, WJ; Green, DM; Langdon, RJ; Mitchell, B; Negrin, R; Szatrowski, TP; Thigpen, JT; Von Hoff, D; Wasserman, TH; Winer, EP; Pfister, DG
      American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants

      JOURNAL OF CLINICAL ONCOLOGY
    8. Kirschenbaum, A; Mano-Negrin, R
      Underlying labor market dimensions of "Opportunities": The case of employee turnover

      HUMAN RELATIONS
    9. HELLSTROMLINDBERG E; NEGRIN R; STEIN R; KRANTZ S; LINDBERG G; VARDIMAN J; OST A; GREENBERG P
      ERYTHROID RESPONSE TO TREATMENT WITH G-CSF PLUS ERYTHROPOIETIN FOR THE ANEMIA OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES - PROPOSAL FOR A PREDICTIVE MODEL

      British Journal of Haematology
    10. VERNERIS M; NEGRIN R
      THE EXPRESSION OF APOPTOSIS RELATED MESSENGER-RNA SPECIES IN CYTOKINE-INDUCED KILLER-CELLS

      Blood
    11. NASH R; KURZROCK R; DIPERSIO J; NIMER S; VOSE J; MAHARAJ D; LINKER C; NADEMANEE A; NEGRIN R; ASHBY M; TREMBLAY T; JONES D; APPELBAUM F; CHAMPLIN R
      SAFETY AND ACTIVITY OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS (PTS) WITH DELAYED PLATELET RECOVERY (DPR)

      Blood
    12. HOPPE EG; NEGRIN R
      HSP47, A HOUSEKEEPING SERINE-PROTEASE INHIBITOR AND COLLAGEN CHAPERONE SHARES HOMOLOGY WITH THE ALPHA(2)-DOMAIN OF HLA-A2 AND INHIBITS NON-MHC-I RESTRICTED T-CYTOTOXICITY AND NK-CYTOTOXICITY AGAINST VASCULAR ENDOTHELIAL-CELLS VIA A NOVEL MECHANISM

      Blood
    13. KNOX SJ; GORIS ML; TRISLER K; NEGRIN R; DAVIS T; LILES TM; GRILLOLOPEZ A; CHINN P; VARNS C; NING SC; FOWLER S; DEB N; BECKER M; MARQUEZ C; LEVY R
      YTTRIUM-90-LABELED ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY OF RECURRENTB-CELL LYMPHOMA

      Clinical cancer research
    14. VANDENBERG D; WESSMAN M; MURRAY L; TONG J; CHEN B; CHEN S; SIMONETTI D; KING J; YAMASAKI G; DIGIUSTO R; CARELLA A; FRASSONI F; GORIN NC; SNYDER D; SCIECINSKI I; NEGRIN R; DEISSEROTH A; TSUKAMOTO A; GEARING D; READING C; HOFFMAN R
      LEUKEMIC BURDEN IN SUBPOPULATIONS OF CD34(-BLOOD OF ALPHA-INTERFERON-RESISTANT OR ALPHA-INTERFERON-INTOLERANT PATIENTS WITH CHRONIC MYELOID-LEUKEMIA() CELLS ISOLATED FROM THE MOBILIZED PERIPHERAL)

      Blood
    15. DAVIS TA; GORIS ML; TRISLER KD; NEGRIN R; LILES TM; FOWLER SF; DEB N; BECKER M; MARQUEZ CM; NING S; LEVY R; KNOX S
      (90)YTTRIUM LABELED ANTI-CD20 THERAPY FOR RECURRENT B-CELL LYMPHOMA

      Blood
    16. HELLSTROMLINDBERG E; NEGRIN R; STEIN R; KRANTZ S; VARDIMAN J; OST A; LINDBERG G; GREENBERG P
      EFFICACY OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

      Blood
    17. HOYLE C; NEGRIN R
      A MINIMAL RESIDUAL DISEASE-MODEL OF CML IN SCID MICE

      Blood
    18. MURRAY L; CHEN B; GALY A; CHEN S; TUSHINSKI R; UCHIDA N; NEGRIN R; TRICOT G; JAGANNATH S; VESOLE D; BARLOGIE B; HOFFMAN R; TSUKAMOTO A
      ENRICHMENT OF HUMAN HEMATOPOIETIC STEM-CELL ACTIVITY IN THE CD34(-1(+)LIN(-) SUBPOPULATION FROM MOBILIZED PERIPHERAL-BLOOD()THY)

      Blood
    19. NEUBAUER A; GREENBERG P; NEGRIN R; GINZTON N; LIU E
      MUTATIONS IN THE RAS PROTOONCOGENES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Leukemia
    20. MURRAY L; DIGIUSTO D; CHEN B; CHEN S; COMBS J; CONTI A; GALY A; NEGRIN R; TRICOT G; TSUKAMOTO A
      ANALYSIS OF HUMAN HEMATOPOIETIC STEM-CELL POPULATIONS

      Blood cells
    21. TSUKAMOTO AS; READING C; CARELLA A; FRASSONI F; GORIN C; LAPORTE J; NEGRIN R; BLUME K; CUNNINGHAM I; DEISSEROTH A; TRICOT G; BARLOGIE B; TONG J; MURRAY L; VANDENBERG D; HOFFMAN R
      BIOLOGICAL CHARACTERIZATION OF STEM-CELL PRESENT IN MOBILIZED PERIPHERAL-BLOOD OF CML PATIENTS

      Bone marrow transplantation
    22. GREENBERG P; TAYLOR K; LARSON R; KOEFFLER P; NEGRIN R; SABA H; GANSER A; JACUBOWSKI A; GABRILOVE J; MUFTI G; CRUZ J; LANGLEY G; VARDIMAN J; BROWN S; BLAIR C; LEBEAU M
      COMPARISON OF 4 CATEGORIZED RISK SCORING SYSTEMS FOR ANALYZING OUTCOME IN GCSF-TREATED AND OBSERVED PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME (MDS)

      Blood
    23. FLEMING WH; ALVERNAS J; FLEMING NC; NEGRIN R; LONG G; CATOLICO M; WONG R; BLUME KG; CHAO NJ
      A RANDOMIZED STUDY OF ERYTHROPOIETIN IN PATIENTS UNDERGOING HLA-MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    24. VANDENBERG D; CARELLA A; NEGRIN R; SNYDER D; GORIN NC; DEISSEROTH A; READING C; CLAXTON D; LIANG J; WESSMAN M; SIMONETTI D; CHEN S; MURRAY L; HOFFMAN R
      POTENTIAL USE OF NORMAL STEM-CELLS ISOLATED FROM MOBILIZED PERIPHERAL-BLOOD OF CML PATIENTS AS AN AUTOGRAFT

      Blood
    25. LEFTEROVA P; NEGRIN R; NEUBAUER A; HUHN D; BLUME K; SCHMIDTWOLF I
      EFFICIENT GENERATION AND CHARACTERIZATION OF TUMOR-CELL SUBCLONES WITH DIFFERENT ADHESION PATHWAYS INVOLVED IN CELL-LYSIS

      Haematologica
    26. GREENBERG P; TAYLOR K; LARSON R; KOEFFLER P; NEGRIN R; SABA H; GANSER A; JAKUBOWSKI A; GABRILOVE J; MUFTI G; CRUZ J; HAMMOND W; BROUDY V; LANGLEY GR; KEATING A; VARDIMAN J; LAMBORN K; BROWN S
      PHASE-III RANDOMIZED MULTICENTER TRIAL OF G-CSF VS OBSERVATION FOR MYELODYSPLASTIC SYNDROMES (MDS)

      Blood
    27. LEBEAU M; TAYLOR K; LARSON R; KOEFFLER P; NEGRIN R; SABA H; GANSER A; JAKUBOWSKI A; GABRILOVE J; MUFTI GJ; CRUZ J; LANGLEY G; VARDIMAN J; DAVIS M; GREENBERG P
      THE PROGNOSTIC-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES (MDS) FOLLOWING G-CSF

      Blood
    28. KOHLER S; BUSQUE L; DEHART D; LEBEAU M; NEGRIN R; GANSER A; GREENBERG P; GILLILAND DG
      CLONALITY ANALYSIS IN MYELODYSPLASIA (MDS) PATIENTS TREATED WITH G-CSF

      Blood
    29. JUREMA M; HUNGER S; NEGRIN R; CLEARY M
      ASSESSMENT OF MINIMAL RESIDUAL DISEASE (MRD) IN AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION FOR MULTIPLE-MYELOMA (MM)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 12:20:11